advertisement
Stalmans I 21
Showing records 1 to 21 | Display all abstracts from Stalmans I106729 The natural history of untreated ocular hypertension and glaucoma
Lauwers A
Survey of Ophthalmology 2023; 68: 388-424
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
José P
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Melgarejo JD; Eijgen JV
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Teixeira FJ
British Journal of Ophthalmology 2022; 106: 1399-1405
106729 The natural history of untreated ocular hypertension and glaucoma
Barbosa Breda J; Stalmans I
Survey of Ophthalmology 2023; 68: 388-424
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Barão R
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Wei D; Maestre GE
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Sousa DC; Marques RE
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Al-Aswad LA
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Barata ADO
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Liao CT; Mena LJ
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Marques-Neves C
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Vanassche T
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Alves M
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Janssens S
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Papoila AL
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Verhamme P
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Stalmans I; Silva JP
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Keer KV; Stalmans I
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Abegão Pinto L
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Zhang ZY
Frontiers in cardiovascular medicine 2022; 9: 1024044